322 related articles for article (PubMed ID: 14531460)
1. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
Rawat S; Jain SK
Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
[TBL] [Abstract][Full Text] [Related]
2. Molecular inclusion of rofecoxib with cyclodextrin: pharmacological properties in laboratory animals.
Baboota S; Dhaliwal M; Kohli K; Ali J
Pharmazie; 2004 Mar; 59(3):233-4. PubMed ID: 15074602
[TBL] [Abstract][Full Text] [Related]
3. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
4. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins.
Chandra Sekhara Rao G; Satish Kumar M; Mathivanan N; Bhanoji Rao ME
Pharmazie; 2004 Aug; 59(8):627-30. PubMed ID: 15378853
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
Chowdary KP; Nalluri BN
Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
[TBL] [Abstract][Full Text] [Related]
7. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.
Patel HM; Suhagia BN; Shah SA; Rathod IS; Parmar VK
Acta Pharm; 2007 Sep; 57(3):351-9. PubMed ID: 17878114
[TBL] [Abstract][Full Text] [Related]
9. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
Veiga F; Fernandes C; Maincent P
Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
[TBL] [Abstract][Full Text] [Related]
10. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
11. Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib.
Singh I; Aboul-Enein HY
Pharmazie; 2007 Apr; 62(4):284-6. PubMed ID: 17484284
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note.
Baboota S; Dhaliwal M; Kohli K
AAPS PharmSciTech; 2005 Sep; 6(1):E83-90. PubMed ID: 16353967
[TBL] [Abstract][Full Text] [Related]
13. Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide.
Al-Marzouqi AH; Shehatta I; Jobe B; Dowaidar A
J Pharm Sci; 2006 Feb; 95(2):292-304. PubMed ID: 16372306
[TBL] [Abstract][Full Text] [Related]
14. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
[TBL] [Abstract][Full Text] [Related]
16. Dissolution properties of praziquantel-beta-cyclodextrin systems.
el-Arini SK; Leuenberger H
Pharm Dev Technol; 1996 Oct; 1(3):307-15. PubMed ID: 9552314
[TBL] [Abstract][Full Text] [Related]
17. Interactions of griseofulvin with cyclodextrins in solid binary systems.
Veiga MD; Díaz PJ; Ahsan F
J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
[TBL] [Abstract][Full Text] [Related]
18. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
19. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
20. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
